In the 1990s, neuroscientists identified a class of drugs that showed promise in the area of stroke. NMDA receptor antagonists could limit damage to the brain in animal models of stroke. But one problem complicated testing ...
Feb 27, 2015
0
96
A new study by University at Buffalo researchers has revealed that the absence of a single interaction within a brain receptor reduces its activity. The discovery advances the understanding of how certain brain diseases arise, ...
Jan 14, 2021
0
41
New images from scientists at Cold Spring Harbor Laboratory (CSHL) reveal for the first time the three-dimensional structures of a set of molecules critical for healthy brain function.
Nov 2, 2022
0
38
The prognosis for the sick child, who hadn't responded to standard treatment, was dire. But a team of Rutgers physicians believed there might be hope despite the conventional wisdom against pursuing any further treatment.
Oct 27, 2022
0
39
A new study of young people experiencing a first episode of psychosis reports elevations in the brain chemicals glutamate and glycine. Published in Biological Psychiatry, the study led by Dr. Dost Öngür of Harvard Medical ...
Oct 11, 2017
0
8
Since the 1960s, psychiatrists have been hunting for substances made by the body that might accumulate in abnormally high levels to produce the symptoms associated with schizophrenia. In particular, there was a search for ...
Mar 14, 2013
0
0
Know your target. Especially if your target is coming into focus for treating diseases such as schizophrenia and treatment-resistant depression.
Jun 28, 2018
0
24
MIT neuroscientists have discovered that the adult brain contains millions of "silent synapses"—immature connections between neurons that remain inactive until they're recruited to help form new memories.
Nov 30, 2022
0
105
A small percentage of people diagnosed with a mysterious neurological condition may only experience psychiatric changes - such as delusional thinking, hallucinations, and aggressive behavior - according to a new study by ...
Jul 26, 2013
0
0
(Medical Xpress)—In a surprising discovery, neuroscientists have found that a breakdown product of cholesterol in the brain may be a target for developing new drugs to treat schizophrenia and other mental illnesses.
Jan 29, 2014
0
0
